Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma
To evaluate and predict long-term clinical outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma by a multicenter study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ultrasound-guided thermal ablation | Procedure | ultrasound-guided thermal ablation to treat tumor |
| Measure | Description | Time Frame |
|---|---|---|
| rate of disease progression | cervical lymph node metastases, recurrent tumors and persistent tumors confirmed by pathology | through study completion, an average of 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of complications | complications of ablation | 1 week |
| Rate of tumor disappearance | complete disappearance of ablated tumor on ultrasound and contrast-enhanced ultrasound |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients with papillary thyroid carcinoma who refuse surgery or active surveillance and choose thermal ablation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lin Yan, MD | Contact | 13811237313 ext 86 | gemma-y@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Yukun Luo | Chinese PLA General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese PLA General Hospital | Recruiting | Beijing | Beijing Municipality | 100853 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000077273 | Thyroid Cancer, Papillary |
| ID | Term |
|---|---|
| D000231 | Adenocarcinoma, Papillary |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
Not provided
Not provided
| ID | Term |
|---|---|
| D020728 | Transurethral Resection of Prostate |
| ID | Term |
|---|---|
| D011468 | Prostatectomy |
| D013521 | Urologic Surgical Procedures, Male |
| D013520 | Urologic Surgical Procedures |
| D013519 | Urogenital Surgical Procedures |
Not provided
Not provided
Not provided
Not provided
Not provided
| through study completion, an average of 6 months |
| Rate of volume reduction | volume reduction of tumor after ablation on ultrasound and contrast-enhanced ultrasound | through study completion, an average of 6 months |
| rate of change of thyroid function | thyroid function test, including free triiodothyronine, free thyroxine, thyroid stimulating hormone, thyroid peroxidase antibody and anti-thyroglobulin antibodies | through study completion, an average of 6 months |
| rate of delayed surgery | patients underwent surgery after ablation because of anxiety | through study completion, an average of 1 year |
| D009370 |
| Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D013964 | Thyroid Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D006258 | Head and Neck Neoplasms |
| D004700 | Endocrine System Diseases |
| D013959 | Thyroid Diseases |
| D013514 | Surgical Procedures, Operative |